课题基金 / 基金详情

Carboxymethyl starch: biocompatible carrier for controlled release of artemisinin and peschiera fuschiaefolia antimalaria combination

Carboxymethyl starch: biocompatible carrier for controlled release of artemisinin and peschiera fuschiaefolia antimalaria combination
羧甲基淀粉:用于控制释放青蒿素和赤果叶抗疟组合物的生物相容性载体
批准号:
455094-2013
负责人:
Mateescu, MirceaAlexandru
金额:
$5.07万
依托单位国家:
加拿大
项目类别:
Collaborative Research and Development Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-01-01 至 2016-12-31

项目摘要

项目成果

Mateescu, MirceaAlexandru的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Malaria, an infectious disease, is still one of the major causes of mortality. In 2010, the World Health Organization (WHO) has estimated about 219 million cases of malaria and up to 1.2 million deaths, mostly among children in Africa. Karici Diagnostics, a Canadian company specialized in diagnostic and treatment of infectious diseases, developed antimalaria natural agents extracted from plant Peschiera fuschiaefolia (Pf). Recently, Karici Diagnostic approached the Artemisinin combination therapy, answering to a need of the WHO, and advanced the hypothesis that the association of Pf and Artemisinin can improve the antimalarial activity, particularly for multidrug resistant strains. Exciting experimental in vitro data were often followed by disappointing in vivo results because of the insufficient concentration of drug due to poor water solubility, low absorption and undesirable accumulation often with harmful side effects. To overcome these problems, Karici Diagnostic investigated in collaboration with UQÀM the development of suitable drug carrier system. This system is mainly based on a starch derivative used as support to protect these bioactive agents during stomach transit and to transport them at the absorption sites. The technology concept consists in adding carboxyl groups onto the starch chain in order to promote the formation of a compact gel-like structure expected to be mechanically stable in acidic biological medium. This biomaterial is novel for pharmaceutical sustained release forms. Since the proposed antimalarial agents are natural and their association is novel, there are not standard methods to measure these bioactive agents. For this reason, the challenges in the present project concern not only the development of suitable carriers, but also to propose new analytical methods to quantitatively determine the active Pf alone and the Artemisinin/Pf combination. In addition to the economic benefits for the partner company, the present project also enables the formation of highly qualified personel and students training making their knowledge more relevant to their future professional career.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Design of self-assembling materials for challenging drug formulations and cell-culture devices
  • 批准号:
    RGPIN-2018-06912
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.04万
  • 财政年份:
    2022
  • 负责人:
    Mateescu, MirceaAlexandru
  • 依托单位:
Design of self-assembling materials for challenging drug formulations and cell-culture devices
  • 批准号:
    RGPIN-2018-06912
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.04万
  • 财政年份:
    2021
  • 负责人:
    Mateescu, MirceaAlexandru
  • 依托单位:
Design of self-assembling materials for challenging drug formulations and cell-culture devices
  • 批准号:
    RGPIN-2018-06912
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.04万
  • 财政年份:
    2020
  • 负责人:
    Mateescu, MirceaAlexandru
  • 依托单位:
Design of self-assembling materials for challenging drug formulations and cell-culture devices
  • 批准号:
    RGPIN-2018-06912
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.04万
  • 财政年份:
    2019
  • 负责人:
    Mateescu, MirceaAlexandru
  • 依托单位:
海外基金